Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy defined by stromal desmoplasia, inflammation, and an immunosuppressive tumor microenvironment (TME) enriched for innate immune cells and characterized by effector T-cell dysfunction. Beyond malignant epithelial cells, the PDAC TME is composed predominantl...
Andrew Adams, H. Amirian, C. Rafie et al.· Cancer Research· 0 citations
Flow cytometry demonstrated that IL-33-IL1RAP signaling selectively induced CXCR2 expression and CXCR2-dependent trafficking in IL1RAP-competent J774M cells, a critical determinant of CXCR2-dependent neutrophil trafficking in PDAC.
Harper M. Marsh, Andrew Adams, H. Amirian et al.· Cancer Research· 0 citations
Pancreatic stellate cells (PSCs) are a principal source of cancer-associated fibroblasts (CAF) in pancreatic ductal adenocarcinoma (PDAC), yet the mechanisms that convert tumor-derived inflammatory cues into a persistent, CAF-like state remain poorly defined. We previously identified tumor cell-intrinsic p38α MAP...
Sayan Chakraborty, Camille Acevedo, Samara P. Singh et al.· Cancer Research· 0 citations
This work identified p38α MAPK (p38α; MAPK14) as a key regulator of inflammatory CAF activation and collagen remodeling and implicates it as a central mediator of stromal remodeling and therapeutic resistance in pancreatic cancer.
Camille Acevedo, Sayan Chakraborty, Samara P. Singh et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.